Citadel Advisors’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $53.4K | Sell |
28,538
-68,774
| -71% | -$129K | ﹤0.01% | 5441 |
|
2025
Q1 | $173K | Buy |
97,312
+35,277
| +57% | +$62.8K | ﹤0.01% | 4930 |
|
2024
Q4 | $196K | Buy |
62,035
+54,591
| +733% | +$172K | ﹤0.01% | 4905 |
|
2024
Q3 | $15.3K | Sell |
7,444
-485,692
| -98% | -$1M | ﹤0.01% | 5389 |
|
2024
Q2 | $720K | Sell |
493,136
-24,440
| -5% | -$35.7K | ﹤0.01% | 3408 |
|
2024
Q1 | $1.21M | Buy |
517,576
+109,854
| +27% | +$257K | ﹤0.01% | 2997 |
|
2023
Q4 | $824K | Buy |
407,722
+171,456
| +73% | +$346K | ﹤0.01% | 3229 |
|
2023
Q3 | $1.14M | Sell |
236,266
-22,627
| -9% | -$110K | ﹤0.01% | 2914 |
|
2023
Q2 | $1.77M | Sell |
258,893
-35,900
| -12% | -$246K | ﹤0.01% | 2524 |
|
2023
Q1 | $2.13M | Sell |
294,793
-2,201
| -0.7% | -$15.9K | ﹤0.01% | 2478 |
|
2022
Q4 | $3.81M | Buy |
296,994
+36,974
| +14% | +$474K | ﹤0.01% | 2023 |
|
2022
Q3 | $3.67M | Buy |
260,020
+26,765
| +11% | +$378K | ﹤0.01% | 2142 |
|
2022
Q2 | $2.87M | Sell |
233,255
-1,256
| -0.5% | -$15.5K | ﹤0.01% | 2392 |
|
2022
Q1 | $3.98M | Buy |
234,511
+3,982
| +2% | +$67.6K | ﹤0.01% | 2285 |
|
2021
Q4 | $5.57M | Buy |
230,529
+131,336
| +132% | +$3.17M | ﹤0.01% | 2016 |
|
2021
Q3 | $2.91M | Buy |
99,193
+2,249
| +2% | +$66.1K | ﹤0.01% | 2589 |
|
2021
Q2 | $2.46M | Buy |
96,944
+88,759
| +1,084% | +$2.25M | ﹤0.01% | 2980 |
|
2021
Q1 | $158K | Buy |
8,185
+2,711
| +50% | +$52.3K | ﹤0.01% | 5570 |
|
2020
Q4 | $80K | Sell |
5,474
-131,262
| -96% | -$1.92M | ﹤0.01% | 4748 |
|
2020
Q3 | $3.08M | Buy |
+136,736
| New | +$3.08M | ﹤0.01% | 1901 |
|
2020
Q2 | – | Sell |
-1,069
| Closed | -$9K | – | 5409 |
|
2020
Q1 | $9K | Buy |
+1,069
| New | +$9K | ﹤0.01% | 4750 |
|
2019
Q4 | – | Sell |
-1,422
| Closed | -$14K | – | 5217 |
|
2019
Q3 | $14K | Buy |
+1,422
| New | +$14K | ﹤0.01% | 4559 |
|